Methylphenidate and haloperidol in children. Effects on attention, memory, and activity

Area of Science:

• Child and Adolescent Psychiatry
• Neuropharmacology
• Cognitive Psychology

Background:

• Hyperactivity and unsocialized-aggressive behaviors in children present complex treatment challenges.
• Understanding the differential cognitive effects of psychostimulants and antipsychotics is crucial for effective management.

Purpose of the Study:

• To compare the cognitive effects of methylphenidate hydrochloride, haloperidol (two doses), and placebo in children with hyperactivity or unsocialized-aggressive behaviors.
• To investigate the impact of these medications on attention, memory, reaction time, and activity levels.

Main Methods:

• Exploratory double-blind crossover study design.
• Twenty-four children participated, receiving four conditions: methylphenidate (0.3 mg/kg), haloperidol (0.25 mg/kg), haloperidol (0.05 mg/kg), and placebo.
• Randomized Latin square design for drug order.
• Cognitive assessments conducted after each 18-day trial period.

Main Results:

• Methylphenidate and the low dose of haloperidol showed small but facilitative effects on cognitive performance.
• A high dose of haloperidol suggested a slight deterioration in cognitive performance.
• No significant differences in cognitive effects were observed based on diagnosis.

Conclusions:

• Methylphenidate and low-dose haloperidol may offer cognitive benefits in specific pediatric populations.
• High-dose haloperidol warrants caution regarding potential cognitive side effects.
• Further research is needed to elucidate the nuanced cognitive profiles associated with these medications in children.